A Double-blinded, Randomized Control Trial of Prophylactic Ondansetron in a Post-operative Cardiac Surgery Population for Post-operative Nausea and Vomiting
Latest Information Update: 24 Sep 2020
At a glance
- Drugs Ondansetron (Primary)
- Indications Postoperative nausea and vomiting
- Focus Therapeutic Use
- 17 Sep 2020 Primary endpoint (Occurrence of Post-operative Nausea and Vomiting (PONV)) has been met according to the results published in the Anesthesia and Analgesia.
- 17 Sep 2020 Results published in the Anesthesia and Analgesia
- 10 Oct 2018 Status changed from recruiting to completed.